nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—asthma—chronic obstructive pulmonary disease	0.228	1	CtDrD
Budesonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.147	0.514	CiPCiCtD
Budesonide—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.139	0.486	CiPCiCtD
Budesonide—Prednisone—chronic obstructive pulmonary disease	0.104	0.506	CrCtD
Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.101	0.494	CrCtD
Budesonide—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0252	0.293	CbGbCtD
Budesonide—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0238	0.277	CbGbCtD
Budesonide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0104	0.121	CbGbCtD
Budesonide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00705	0.0819	CbGbCtD
Budesonide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00673	0.0781	CbGbCtD
Budesonide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.006	0.0696	CbGbCtD
Budesonide—Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.00407	0.0275	CrCrCtD
Budesonide—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00397	0.0268	CrCrCtD
Budesonide—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00355	0.024	CrCrCtD
Budesonide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00352	0.0409	CbGbCtD
Budesonide—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0034	0.023	CrCrCtD
Budesonide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00332	0.0386	CbGbCtD
Budesonide—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.00332	0.0224	CrCrCtD
Budesonide—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.0032	0.0216	CrCrCtD
Budesonide—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0032	0.0216	CrCrCtD
Budesonide—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.0211	CrCrCtD
Budesonide—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.0211	CrCrCtD
Budesonide—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.0211	CrCrCtD
Budesonide—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.0211	CrCrCtD
Budesonide—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00311	0.021	CrCrCtD
Budesonide—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00303	0.0205	CrCrCtD
Budesonide—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00302	0.0204	CrCrCtD
Budesonide—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00295	0.0199	CrCrCtD
Budesonide—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00295	0.0199	CrCrCtD
Budesonide—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00294	0.0199	CrCrCtD
Budesonide—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00287	0.0194	CrCrCtD
Budesonide—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00286	0.0193	CrCrCtD
Budesonide—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00286	0.0193	CrCrCtD
Budesonide—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00286	0.0193	CrCrCtD
Budesonide—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00286	0.0193	CrCrCtD
Budesonide—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0189	CrCrCtD
Budesonide—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0189	CrCrCtD
Budesonide—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0189	CrCrCtD
Budesonide—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0189	CrCrCtD
Budesonide—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0189	CrCrCtD
Budesonide—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00279	0.0189	CrCrCtD
Budesonide—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00273	0.0184	CrCrCtD
Budesonide—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00272	0.0184	CrCrCtD
Budesonide—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.018	CrCrCtD
Budesonide—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.0026	0.0176	CrCrCtD
Budesonide—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.0026	0.0176	CrCrCtD
Budesonide—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.0026	0.0176	CrCrCtD
Budesonide—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.0026	0.0175	CrCrCtD
Budesonide—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.0026	0.0175	CrCrCtD
Budesonide—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.0026	0.0175	CrCrCtD
Budesonide—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.0026	0.0175	CrCrCtD
Budesonide—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.0026	0.0175	CrCrCtD
Budesonide—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00254	0.0171	CrCrCtD
Budesonide—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00254	0.0171	CrCrCtD
Budesonide—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00254	0.0171	CrCrCtD
Budesonide—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00249	0.0168	CrCrCtD
Budesonide—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00243	0.0164	CrCrCtD
Budesonide—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00243	0.0164	CrCrCtD
Budesonide—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00234	0.0158	CrCrCtD
Budesonide—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.0154	CrCrCtD
Budesonide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.1	CbGpPWpGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000153	0.0887	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000125	0.0726	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	7.81e-05	0.0452	CbGpPWpGaD
Budesonide—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	6.67e-05	0.282	CrCbGaD
Budesonide—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.272	CrCbGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.0368	CbGpPWpGaD
Budesonide—Dexamethasone—NOS2—chronic obstructive pulmonary disease	5.44e-05	0.23	CrCbGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	4.88e-05	0.0282	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	4.85e-05	0.0281	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.0219	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	3.29e-05	0.019	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.019	CbGpPWpGaD
Budesonide—Anxiety—Montelukast—chronic obstructive pulmonary disease	3.24e-05	0.00071	CcSEcCtD
Budesonide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	3.24e-05	0.000709	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	3.23e-05	0.000708	CcSEcCtD
Budesonide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	3.23e-05	0.000707	CcSEcCtD
Budesonide—Cough—Salbutamol—chronic obstructive pulmonary disease	3.22e-05	0.000704	CcSEcCtD
Budesonide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	3.19e-05	0.000698	CcSEcCtD
Budesonide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	3.19e-05	0.000698	CcSEcCtD
Budesonide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	3.18e-05	0.000697	CcSEcCtD
Budesonide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	3.18e-05	0.000696	CcSEcCtD
Budesonide—Infection—Arformoterol—chronic obstructive pulmonary disease	3.16e-05	0.000693	CcSEcCtD
Budesonide—Infection—Formoterol—chronic obstructive pulmonary disease	3.16e-05	0.000693	CcSEcCtD
Budesonide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	3.14e-05	0.000687	CcSEcCtD
Budesonide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	3.14e-05	0.000687	CcSEcCtD
Budesonide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	3.14e-05	0.000687	CcSEcCtD
Budesonide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	3.14e-05	0.000687	CcSEcCtD
Budesonide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	3.13e-05	0.000685	CcSEcCtD
Budesonide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	3.12e-05	0.000684	CcSEcCtD
Budesonide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	3.12e-05	0.000684	CcSEcCtD
Budesonide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	3.12e-05	0.000683	CcSEcCtD
Budesonide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	3.12e-05	0.000683	CcSEcCtD
Budesonide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	3.11e-05	0.000681	CcSEcCtD
Budesonide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	3.11e-05	0.000681	CcSEcCtD
Budesonide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	3.1e-05	0.000679	CcSEcCtD
Budesonide—Infection—Montelukast—chronic obstructive pulmonary disease	3.1e-05	0.000679	CcSEcCtD
Budesonide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	3.09e-05	0.000678	CcSEcCtD
Budesonide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	3.09e-05	0.000678	CcSEcCtD
Budesonide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	3.08e-05	0.000675	CcSEcCtD
Budesonide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	3.07e-05	0.000672	CcSEcCtD
Budesonide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	3.06e-05	0.000671	CcSEcCtD
Budesonide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	3.06e-05	0.00067	CcSEcCtD
Budesonide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	3.05e-05	0.000669	CcSEcCtD
Budesonide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	3.03e-05	0.000664	CcSEcCtD
Budesonide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	3.01e-05	0.000659	CcSEcCtD
Budesonide—Infection—Salbutamol—chronic obstructive pulmonary disease	2.99e-05	0.000654	CcSEcCtD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	2.99e-05	0.0173	CbGpPWpGaD
Budesonide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	2.96e-05	0.000648	CcSEcCtD
Budesonide—Shock—Salbutamol—chronic obstructive pulmonary disease	2.96e-05	0.000648	CcSEcCtD
Budesonide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	2.96e-05	0.000647	CcSEcCtD
Budesonide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	2.95e-05	0.000646	CcSEcCtD
Budesonide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	2.94e-05	0.000643	CcSEcCtD
Budesonide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	2.92e-05	0.00064	CcSEcCtD
Budesonide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	2.91e-05	0.000637	CcSEcCtD
Budesonide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	2.91e-05	0.000637	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	2.9e-05	0.000636	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	2.9e-05	0.000636	CcSEcCtD
Budesonide—Insomnia—Formoterol—chronic obstructive pulmonary disease	2.88e-05	0.000631	CcSEcCtD
Budesonide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	2.88e-05	0.000631	CcSEcCtD
Budesonide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	2.87e-05	0.000628	CcSEcCtD
Budesonide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	2.86e-05	0.000627	CcSEcCtD
Budesonide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	2.86e-05	0.0166	CbGpPWpGaD
Budesonide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	2.85e-05	0.000624	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	2.84e-05	0.000623	CcSEcCtD
Budesonide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	2.84e-05	0.000622	CcSEcCtD
Budesonide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	2.84e-05	0.000622	CcSEcCtD
Budesonide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	2.83e-05	0.00062	CcSEcCtD
Budesonide—Somnolence—Formoterol—chronic obstructive pulmonary disease	2.83e-05	0.00062	CcSEcCtD
Budesonide—Insomnia—Montelukast—chronic obstructive pulmonary disease	2.82e-05	0.000618	CcSEcCtD
Budesonide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	2.8e-05	0.000614	CcSEcCtD
Budesonide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	2.8e-05	0.000614	CcSEcCtD
Budesonide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	2.8e-05	0.000614	CcSEcCtD
Budesonide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	2.79e-05	0.000612	CcSEcCtD
Budesonide—Somnolence—Montelukast—chronic obstructive pulmonary disease	2.77e-05	0.000607	CcSEcCtD
Budesonide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	2.77e-05	0.000606	CcSEcCtD
Budesonide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	2.76e-05	0.000605	CcSEcCtD
Budesonide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	2.75e-05	0.000602	CcSEcCtD
Budesonide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	2.75e-05	0.000602	CcSEcCtD
Budesonide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	2.75e-05	0.000601	CcSEcCtD
Budesonide—Fatigue—Formoterol—chronic obstructive pulmonary disease	2.75e-05	0.000601	CcSEcCtD
Budesonide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	2.75e-05	0.000601	CcSEcCtD
Budesonide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	2.75e-05	0.0159	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	2.74e-05	0.0159	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	2.74e-05	0.0006	CcSEcCtD
Budesonide—Constipation—Formoterol—chronic obstructive pulmonary disease	2.72e-05	0.000597	CcSEcCtD
Budesonide—Pain—Arformoterol—chronic obstructive pulmonary disease	2.72e-05	0.000597	CcSEcCtD
Budesonide—Pain—Formoterol—chronic obstructive pulmonary disease	2.72e-05	0.000597	CcSEcCtD
Budesonide—Constipation—Arformoterol—chronic obstructive pulmonary disease	2.72e-05	0.000597	CcSEcCtD
Budesonide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	2.72e-05	0.000596	CcSEcCtD
Budesonide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000595	CcSEcCtD
Budesonide—Amnesia—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000595	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	2.71e-05	0.0157	CbGpPWpGaD
Budesonide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	2.7e-05	0.000591	CcSEcCtD
Budesonide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	2.69e-05	0.00059	CcSEcCtD
Budesonide—Fatigue—Montelukast—chronic obstructive pulmonary disease	2.69e-05	0.000589	CcSEcCtD
Budesonide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	2.68e-05	0.000587	CcSEcCtD
Budesonide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	2.67e-05	0.000586	CcSEcCtD
Budesonide—Pain—Montelukast—chronic obstructive pulmonary disease	2.67e-05	0.000584	CcSEcCtD
Budesonide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	2.66e-05	0.000583	CcSEcCtD
Budesonide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	2.65e-05	0.00058	CcSEcCtD
Budesonide—Prednisone—ALB—chronic obstructive pulmonary disease	2.65e-05	0.112	CrCbGaD
Budesonide—Purpura—Prednisone—chronic obstructive pulmonary disease	2.65e-05	0.00058	CcSEcCtD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	2.64e-05	0.0153	CbGpPWpGaD
Budesonide—Rash—Aminophylline—chronic obstructive pulmonary disease	2.64e-05	0.000578	CcSEcCtD
Budesonide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	2.64e-05	0.000577	CcSEcCtD
Budesonide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	2.63e-05	0.000576	CcSEcCtD
Budesonide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	2.63e-05	0.000575	CcSEcCtD
Budesonide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	2.63e-05	0.000575	CcSEcCtD
Budesonide—Headache—Aminophylline—chronic obstructive pulmonary disease	2.62e-05	0.000574	CcSEcCtD
Budesonide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	2.61e-05	0.000573	CcSEcCtD
Budesonide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	2.61e-05	0.000572	CcSEcCtD
Budesonide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	2.61e-05	0.00057	CcSEcCtD
Budesonide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	2.61e-05	0.00057	CcSEcCtD
Budesonide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	2.6e-05	0.000569	CcSEcCtD
Budesonide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	2.59e-05	0.000568	CcSEcCtD
Budesonide—Pain—Salbutamol—chronic obstructive pulmonary disease	2.57e-05	0.000563	CcSEcCtD
Budesonide—Constipation—Salbutamol—chronic obstructive pulmonary disease	2.57e-05	0.000563	CcSEcCtD
Budesonide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	2.55e-05	0.000559	CcSEcCtD
Budesonide—Urticaria—Formoterol—chronic obstructive pulmonary disease	2.53e-05	0.000554	CcSEcCtD
Budesonide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	2.53e-05	0.000554	CcSEcCtD
Budesonide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	2.52e-05	0.000551	CcSEcCtD
Budesonide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	2.52e-05	0.000551	CcSEcCtD
Budesonide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	2.52e-05	0.000551	CcSEcCtD
Budesonide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	2.52e-05	0.000551	CcSEcCtD
Budesonide—Affect lability—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.00055	CcSEcCtD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	2.51e-05	0.0145	CbGpPWpGaD
Budesonide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	2.51e-05	0.00055	CcSEcCtD
Budesonide—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	2.5e-05	0.105	CrCbGaD
Budesonide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000546	CcSEcCtD
Budesonide—Rash—Tiotropium—chronic obstructive pulmonary disease	2.49e-05	0.000545	CcSEcCtD
Budesonide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	2.49e-05	0.000545	CcSEcCtD
Budesonide—Nausea—Aminophylline—chronic obstructive pulmonary disease	2.49e-05	0.000544	CcSEcCtD
Budesonide—Urticaria—Montelukast—chronic obstructive pulmonary disease	2.48e-05	0.000543	CcSEcCtD
Budesonide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	2.48e-05	0.000543	CcSEcCtD
Budesonide—Headache—Tiotropium—chronic obstructive pulmonary disease	2.47e-05	0.000542	CcSEcCtD
Budesonide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	2.47e-05	0.00054	CcSEcCtD
Budesonide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	2.47e-05	0.00054	CcSEcCtD
Budesonide—Face oedema—Prednisone—chronic obstructive pulmonary disease	2.46e-05	0.000539	CcSEcCtD
Budesonide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	2.46e-05	0.000539	CcSEcCtD
Budesonide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	2.44e-05	0.000534	CcSEcCtD
Budesonide—Irritability—Prednisone—chronic obstructive pulmonary disease	2.43e-05	0.000533	CcSEcCtD
Budesonide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	2.43e-05	0.000532	CcSEcCtD
Budesonide—Mood swings—Prednisone—chronic obstructive pulmonary disease	2.42e-05	0.000529	CcSEcCtD
Budesonide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	2.39e-05	0.000523	CcSEcCtD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.0138	CbGpPWpGaD
Budesonide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	2.38e-05	0.000521	CcSEcCtD
Budesonide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	2.38e-05	0.000521	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	2.36e-05	0.0137	CbGpPWpGaD
Budesonide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	2.35e-05	0.000514	CcSEcCtD
Budesonide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	2.35e-05	0.000514	CcSEcCtD
Budesonide—Nausea—Tiotropium—chronic obstructive pulmonary disease	2.34e-05	0.000513	CcSEcCtD
Budesonide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	2.34e-05	0.000512	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	2.33e-05	0.0135	CbGpPWpGaD
Budesonide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000508	CcSEcCtD
Budesonide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	2.3e-05	0.000503	CcSEcCtD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	2.29e-05	0.0133	CbGpPWpGaD
Budesonide—Asthenia—Formoterol—chronic obstructive pulmonary disease	2.29e-05	0.000501	CcSEcCtD
Budesonide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	2.29e-05	0.000501	CcSEcCtD
Budesonide—Pruritus—Formoterol—chronic obstructive pulmonary disease	2.25e-05	0.000494	CcSEcCtD
Budesonide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	2.25e-05	0.000494	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	2.24e-05	0.013	CbGpPWpGaD
Budesonide—Asthenia—Montelukast—chronic obstructive pulmonary disease	2.24e-05	0.00049	CcSEcCtD
Budesonide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000486	CcSEcCtD
Budesonide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	2.22e-05	0.000485	CcSEcCtD
Budesonide—Pruritus—Montelukast—chronic obstructive pulmonary disease	2.21e-05	0.000483	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	2.18e-05	0.0126	CbGpPWpGaD
Budesonide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	2.18e-05	0.000477	CcSEcCtD
Budesonide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	2.18e-05	0.000477	CcSEcCtD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.0126	CbGpPWpGaD
Budesonide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	2.16e-05	0.000473	CcSEcCtD
Budesonide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	2.15e-05	0.00047	CcSEcCtD
Budesonide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	2.14e-05	0.000468	CcSEcCtD
Budesonide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	2.13e-05	0.000466	CcSEcCtD
Budesonide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	2.11e-05	0.000461	CcSEcCtD
Budesonide—Dizziness—Formoterol—chronic obstructive pulmonary disease	2.11e-05	0.000461	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.08e-05	0.012	CbGpPWpGaD
Budesonide—Dizziness—Montelukast—chronic obstructive pulmonary disease	2.06e-05	0.000452	CcSEcCtD
Budesonide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	2.06e-05	0.000451	CcSEcCtD
Budesonide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	2.03e-05	0.000444	CcSEcCtD
Budesonide—Vomiting—Formoterol—chronic obstructive pulmonary disease	2.03e-05	0.000444	CcSEcCtD
Budesonide—Rash—Formoterol—chronic obstructive pulmonary disease	2.01e-05	0.00044	CcSEcCtD
Budesonide—Rash—Arformoterol—chronic obstructive pulmonary disease	2.01e-05	0.00044	CcSEcCtD
Budesonide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	2.01e-05	0.000439	CcSEcCtD
Budesonide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	2.01e-05	0.000439	CcSEcCtD
Budesonide—Weight increased—Prednisone—chronic obstructive pulmonary disease	2.01e-05	0.000439	CcSEcCtD
Budesonide—Headache—Arformoterol—chronic obstructive pulmonary disease	2e-05	0.000437	CcSEcCtD
Budesonide—Headache—Formoterol—chronic obstructive pulmonary disease	2e-05	0.000437	CcSEcCtD
Budesonide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	2e-05	0.0116	CbGpPWpGaD
Budesonide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	1.99e-05	0.000436	CcSEcCtD
Budesonide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	1.99e-05	0.000436	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	1.98e-05	0.0115	CbGpPWpGaD
Budesonide—Vomiting—Montelukast—chronic obstructive pulmonary disease	1.98e-05	0.000434	CcSEcCtD
Budesonide—Rash—Montelukast—chronic obstructive pulmonary disease	1.97e-05	0.000431	CcSEcCtD
Budesonide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	1.97e-05	0.00043	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	1.97e-05	0.0114	CbGpPWpGaD
Budesonide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	1.96e-05	0.000429	CcSEcCtD
Budesonide—Headache—Montelukast—chronic obstructive pulmonary disease	1.95e-05	0.000428	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	1.95e-05	0.0113	CbGpPWpGaD
Budesonide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	1.93e-05	0.000423	CcSEcCtD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.0111	CbGpPWpGaD
Budesonide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	1.91e-05	0.000419	CcSEcCtD
Budesonide—Malaise—Prednisolone—chronic obstructive pulmonary disease	1.91e-05	0.000417	CcSEcCtD
Budesonide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	1.9e-05	0.000416	CcSEcCtD
Budesonide—Rash—Salbutamol—chronic obstructive pulmonary disease	1.9e-05	0.000415	CcSEcCtD
Budesonide—Syncope—Prednisolone—chronic obstructive pulmonary disease	1.9e-05	0.000415	CcSEcCtD
Budesonide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	1.89e-05	0.000415	CcSEcCtD
Budesonide—Nausea—Arformoterol—chronic obstructive pulmonary disease	1.89e-05	0.000414	CcSEcCtD
Budesonide—Nausea—Formoterol—chronic obstructive pulmonary disease	1.89e-05	0.000414	CcSEcCtD
Budesonide—Headache—Salbutamol—chronic obstructive pulmonary disease	1.88e-05	0.000413	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	1.88e-05	0.0109	CbGpPWpGaD
Budesonide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	1.86e-05	0.000407	CcSEcCtD
Budesonide—Nausea—Montelukast—chronic obstructive pulmonary disease	1.85e-05	0.000406	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	1.83e-05	0.0106	CbGpPWpGaD
Budesonide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	1.83e-05	0.0004	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	1.81e-05	0.0105	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.0104	CbGpPWpGaD
Budesonide—Nausea—Salbutamol—chronic obstructive pulmonary disease	1.79e-05	0.000391	CcSEcCtD
Budesonide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	1.78e-05	0.000389	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	1.77e-05	0.0103	CbGpPWpGaD
Budesonide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000388	CcSEcCtD
Budesonide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	1.76e-05	0.000386	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	1.75e-05	0.0101	CbGpPWpGaD
Budesonide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	1.73e-05	0.00038	CcSEcCtD
Budesonide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	1.73e-05	0.000378	CcSEcCtD
Budesonide—Shock—Prednisolone—chronic obstructive pulmonary disease	1.7e-05	0.000372	CcSEcCtD
Budesonide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	1.68e-05	0.000369	CcSEcCtD
Budesonide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	1.67e-05	0.000365	CcSEcCtD
Budesonide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	1.65e-05	0.000361	CcSEcCtD
Budesonide—Flushing—Prednisone—chronic obstructive pulmonary disease	1.64e-05	0.000359	CcSEcCtD
Budesonide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	1.6e-05	0.000351	CcSEcCtD
Budesonide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	1.59e-05	0.000349	CcSEcCtD
Budesonide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	1.56e-05	0.000342	CcSEcCtD
Budesonide—Alopecia—Prednisone—chronic obstructive pulmonary disease	1.56e-05	0.000341	CcSEcCtD
Budesonide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	1.55e-05	0.000339	CcSEcCtD
Budesonide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	1.55e-05	0.000339	CcSEcCtD
Budesonide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	1.54e-05	0.000336	CcSEcCtD
Budesonide—Pain—Prednisolone—chronic obstructive pulmonary disease	1.48e-05	0.000323	CcSEcCtD
Budesonide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	1.45e-05	0.000317	CcSEcCtD
Budesonide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	1.43e-05	0.000312	CcSEcCtD
Budesonide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	1.42e-05	0.000311	CcSEcCtD
Budesonide—Anaemia—Prednisone—chronic obstructive pulmonary disease	1.42e-05	0.000311	CcSEcCtD
Budesonide—Agitation—Prednisone—chronic obstructive pulmonary disease	1.41e-05	0.000309	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.00817	CbGpPWpGaD
Budesonide—Angioedema—Prednisone—chronic obstructive pulmonary disease	1.4e-05	0.000307	CcSEcCtD
Budesonide—Malaise—Prednisone—chronic obstructive pulmonary disease	1.39e-05	0.000303	CcSEcCtD
Budesonide—Vertigo—Prednisone—chronic obstructive pulmonary disease	1.38e-05	0.000302	CcSEcCtD
Budesonide—Syncope—Prednisone—chronic obstructive pulmonary disease	1.38e-05	0.000302	CcSEcCtD
Budesonide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	1.37e-05	0.0003	CcSEcCtD
Budesonide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	1.35e-05	0.000296	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.00777	CbGpPWpGaD
Budesonide—Hypertension—Prednisone—chronic obstructive pulmonary disease	1.33e-05	0.00029	CcSEcCtD
Budesonide—Myalgia—Prednisone—chronic obstructive pulmonary disease	1.31e-05	0.000286	CcSEcCtD
Budesonide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	1.31e-05	0.000286	CcSEcCtD
Budesonide—Anxiety—Prednisone—chronic obstructive pulmonary disease	1.3e-05	0.000285	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	1.3e-05	0.000284	CcSEcCtD
Budesonide—Discomfort—Prednisone—chronic obstructive pulmonary disease	1.29e-05	0.000283	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.00739	CbGpPWpGaD
Budesonide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	1.27e-05	0.000278	CcSEcCtD
Budesonide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	1.25e-05	0.000275	CcSEcCtD
Budesonide—Infection—Prednisone—chronic obstructive pulmonary disease	1.25e-05	0.000273	CcSEcCtD
Budesonide—Shock—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.00027	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.23e-05	0.00712	CbGpPWpGaD
Budesonide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.000269	CcSEcCtD
Budesonide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	1.22e-05	0.000268	CcSEcCtD
Budesonide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	1.22e-05	0.000267	CcSEcCtD
Budesonide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	1.21e-05	0.000265	CcSEcCtD
Budesonide—Anorexia—Prednisone—chronic obstructive pulmonary disease	1.2e-05	0.000262	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.17e-05	0.00678	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.17e-05	0.00676	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.15e-05	0.00669	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	1.14e-05	0.00025	CcSEcCtD
Budesonide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.14e-05	0.00025	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.0066	CbGpPWpGaD
Budesonide—Insomnia—Prednisone—chronic obstructive pulmonary disease	1.13e-05	0.000248	CcSEcCtD
Budesonide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	1.13e-05	0.000247	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.00652	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.00651	CbGpPWpGaD
Budesonide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	1.1e-05	0.000242	CcSEcCtD
Budesonide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	1.09e-05	0.000239	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.0063	CbGpPWpGaD
Budesonide—Rash—Prednisolone—chronic obstructive pulmonary disease	1.09e-05	0.000238	CcSEcCtD
Budesonide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.09e-05	0.000238	CcSEcCtD
Budesonide—Fatigue—Prednisone—chronic obstructive pulmonary disease	1.08e-05	0.000237	CcSEcCtD
Budesonide—Headache—Prednisolone—chronic obstructive pulmonary disease	1.08e-05	0.000237	CcSEcCtD
Budesonide—Constipation—Prednisone—chronic obstructive pulmonary disease	1.07e-05	0.000235	CcSEcCtD
Budesonide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	1.03e-05	0.000226	CcSEcCtD
Budesonide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	1.03e-05	0.000224	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.00594	CbGpPWpGaD
Budesonide—Nausea—Prednisolone—chronic obstructive pulmonary disease	1.02e-05	0.000224	CcSEcCtD
Budesonide—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.96e-06	0.000218	CcSEcCtD
Budesonide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.91e-06	0.000217	CcSEcCtD
Budesonide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.91e-06	0.000217	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	9.74e-06	0.00564	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	9.51e-06	0.00551	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.25e-06	0.00535	CbGpPWpGaD
Budesonide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.24e-06	0.000202	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	9.19e-06	0.00532	CbGpPWpGaD
Budesonide—Asthenia—Prednisone—chronic obstructive pulmonary disease	9e-06	0.000197	CcSEcCtD
Budesonide—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.87e-06	0.000194	CcSEcCtD
Budesonide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.58e-06	0.000188	CcSEcCtD
Budesonide—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.29e-06	0.000182	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.29e-06	0.0048	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.18e-06	0.00474	CbGpPWpGaD
Budesonide—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.97e-06	0.000175	CcSEcCtD
Budesonide—Rash—Prednisone—chronic obstructive pulmonary disease	7.91e-06	0.000173	CcSEcCtD
Budesonide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.9e-06	0.000173	CcSEcCtD
Budesonide—Headache—Prednisone—chronic obstructive pulmonary disease	7.85e-06	0.000172	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	7.83e-06	0.00454	CbGpPWpGaD
Budesonide—Nausea—Prednisone—chronic obstructive pulmonary disease	7.45e-06	0.000163	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.36e-06	0.00426	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	7.17e-06	0.00415	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	6.9e-06	0.004	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	6.72e-06	0.00389	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.72e-06	0.00389	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.45e-06	0.00374	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	6.32e-06	0.00366	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.91e-06	0.00342	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.84e-06	0.00338	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	5.8e-06	0.00336	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.46e-06	0.00316	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	5.41e-06	0.00314	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.91e-06	0.00284	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.84e-06	0.00281	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.68e-06	0.00271	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	4.37e-06	0.00253	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.1e-06	0.00237	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.04e-06	0.00234	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.78e-06	0.00219	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.76e-06	0.00218	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.71e-06	0.00215	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.57e-06	0.00207	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.54e-06	0.00205	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.52e-06	0.00204	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.35e-06	0.00194	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.3e-06	0.00191	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.87e-06	0.00166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.9e-06	0.0011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.85e-06	0.00107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.72e-06	0.000996	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.61e-06	0.000935	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-06	0.000585	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.99e-07	0.000579	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.12e-07	0.000528	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.4e-07	0.000486	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7e-07	0.000406	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.91e-07	0.0004	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.44e-07	0.000373	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.1e-07	0.000353	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.15e-07	0.00024	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.97e-07	0.00023	CbGpPWpGaD
